(Q44525928)

English

Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma

scientific article published in August 2003

Statements

Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma (English)
Italian Oncology Group for Clinical Research

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit